M. Cámara

Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.

A. Llombart-Cussac, E. Carrasco, M. Ramos, 2016, European journal of cancer.

Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

F. Rojo, J. Albanell, A. Lluch, 2014, British Journal of Cancer.